Primer: Challenges in randomized and observational studies

Nature Clinical Practice Rheumatology

Volumn 3, Issue 11, 2007, Pages 661-666

  Landewé, Robert ^a   van der Heijde, Désirée ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

CENSORSHIP; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE REGISTRY; DISEASE SEVERITY; EXTERNAL VALIDITY; GASTROINTESTINAL DISEASE; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MEDICAL RESEARCH; METHODOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUBJECT; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; TREATMENT DURATION;

COHORT STUDIES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTION BIAS; STATISTICS AS TOPIC;

EID: 35649003820     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0626     Document Type: Review

References (18)

1. Barton S (2000) Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ 321: 255-256
2. Pocock SJ and Elbourne DR (2000) Randomized trials or observational tribulations? N Engl J Med 342: 1907-1909
3. Benson K and Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342: 1878-1886
4. Pincus T and Sokka T (2004) Clinical trials in rheumatic diseases: designs and limitations. Rheum Dis Clin North Am 30: 701-724
5. Pincus T and Sokka T (2004) Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa? Ann Rheum Dis 63 (Suppl 2): Ii32-ii39
6. Britton A et al. (1999) Threats to applicability of randomised trials: Exclusions and selective participation. J Health Serv Res Policy 4: 112-121
7. Carnée X and Arnaiz JA (2000). Methodological and political issues in clinical pharmacology research by the year 2000. Eur J Clin Pharmacol 55: 781-785
8. Frieling UM et al. (200) A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study. Arch Dermatol 136: 179-184
9. Krishnan E et al. (2004) Attrition bias in rheumatoid arthritis databanks: A case study of 6,346 patients in 11 databanks and 65, 649 administrations of the Health Assessment Questionnaire. J Rheumatol 31: 1320-1326
10. Farewell VT (2004) Studies of attrition in rheumatological databases. J Rheumatol, 31: 1244-1245
11. Landewé RB (2003) The benefits of early treatment in rheumatoid arthritis: Confounding by indication, and the issue of timing. Arthritis Rheum 46: 1-5
12. van der Heijde D et al. (2005) Presentation and analysis of data on radiographic outcome in clinical trials: Experience from the TEMPO study. Arthritis Rheum 52: 49-60
13. D'Agostino RB (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17: 2265-2281
14. Bukhari MA et al. (2003) Influence of disease-modifying therapy on radiodraphic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum 48: 46-53
15. Fessler BJ et al. (2005) Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 52: 1473-1480
16. Landewé RB et al. (2002) COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention. Arthritis Rheum 46: 347-356
17. Liang KY and Zeger SL (1993) Regression analysis for correlated data. Annu Rev Public Health 14: 43-68
18. Zeger SL and Liang KY (1992) An overview of methods for the analysis of longitudinal data. Stat Med 11: 1825-1839